| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_16ae72d2d198049984d677a7d25f830b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e46cb39df547d2aaf5020d0205ea2a74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3ee4052bd25bab5a8402ebd63718b07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2581347dd22b5329f0c4b5a5b335c320 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-9645
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-224 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40 |
| filingDate |
2010-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e7715ad41adad76ed3925462ef8fa9c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f4a4d72389b2d64eda60f337062b9cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8b224d079e968a9f62597e208ba9510
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8aba4de3de43cf94767f5e89f14d5ac |
| publicationDate |
2011-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011080322-A1 |
| titleOfInvention |
Method of prognosing the outcome of acquired hemophilia and of treatment of hemophilia |
| abstract |
The present invention relates to an anti-factor IX activating catalytic antibody and to a pharmaceutical composition comprising said activating catalytic antibody. The present invention also relates to a method of prognosing the outcome of acquired hemophilia and of treatment of acquired hemophilia, hemophilia A, B and C. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11220554-B2 |
| priorityDate |
2009-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |